Cargando…

Drivers of genomic loss of heterozygosity in leiomyosarcoma are distinct from carcinomas

Leiomyosarcoma (LMS) is a rare, aggressive, mesenchymal tumor. Subsets of LMS have been identified to harbor genomic alterations associated with homologous recombination deficiency (HRD); particularly alterations in BRCA2. Whereas genomic loss of heterozygosity (gLOH) has been used as a surrogate ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seligson, Nathan D., Tang, Joy, Jin, Dexter X., Bennett, Monica P., Elvin, Julia A., Graim, Kiley, Hays, John L., Millis, Sherri Z., Miles, Wayne O., Chen, James L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038792/ https://www.ncbi.nlm.nih.gov/pubmed/35468996 http://dx.doi.org/10.1038/s41698-022-00271-x

Ejemplares similares

Gene partners of the EWSR1 fusion may represent molecularly distinct entities
por: Walker, Victoria, et al.
Publicado: (2023)

Clinical Implications of Genomic Loss of Heterozygosity in Endometrial Carcinoma
por: Bustamante, Bethany, et al.
Publicado: (2021)

Loss of heterozygosity: what is it good for?
por: Ryland, Georgina L., et al.
Publicado: (2015)

Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target
por: Seligson, Nathan D., et al.
Publicado: (2021)

Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges
por: Hsu, Jocelyn Y., et al.
Publicado: (2022)

Common Secondary Genomic Variants Associated With Advanced Epithelioid Hemangioendothelioma
por: Seligson, Nathan D., et al.
Publicado: (2019)

A new method to detect loss of heterozygosity using cohort heterozygosity comparisons
por: Green, Michael R, et al.
Publicado: (2010)

Loss of Heterozygosity Drives Adaptation in Hybrid Yeast
por: Smukowski Heil, Caiti S., et al.
Publicado: (2017)

Loss of Heterozygosity and Its Importance in Evolution
por: Smukowski Heil, Caiti
Publicado: (2023)

Loss of heterozygosity on chromosomes 1 and 11 in carcinoma of the pancreas.
por: Ding, S. F., et al.
Publicado: (1992)

Loss of heterozygosity of the oestrogen receptor gene in breast cancer.
por: Iwase, H., et al.
Publicado: (1995)

Loss of constitutional heterozygosity on chromosomes 5 and 17 in cholangiocarcinoma.
por: Ding, S. F., et al.
Publicado: (1993)

Loss of heterozygosity of TRIM3 in malignant gliomas
por: Boulay, Jean-Louis, et al.
Publicado: (2009)

Analysis of Loss of Heterozygosity in Korean Patients with Keratoacanthoma
por: Ha, Tae-Won, et al.
Publicado: (2005)

Targeting tumor vulnerabilities associated with loss of heterozygosity
por: Rendo, Veronica, et al.
Publicado: (2020)

Fitness benefits of loss of heterozygosity in Saccharomyces hybrids
por: Lancaster, Samuel M., et al.
Publicado: (2019)

Targeting loss of heterozygosity for cancer-specific immunotherapy
por: Hwang, Michael S., et al.
Publicado: (2021)

Polyploidy as an Adaptation against Loss of Heterozygosity in Cancer
por: Archetti, Marco
Publicado: (2022)

Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma
por: Pastorino, Lorenza, et al.
Publicado: (2022)

Loss of heterozygosity at 7p in Wilms' tumour development
por: Powlesland, R M, et al.
Publicado: (2000)

Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan
por: Sheu, J-C, et al.
Publicado: (1999)

Loss of heterozygosity on chromosome 16 in sporadic Wilms' tumour.
por: Grundy, R. G., et al.
Publicado: (1998)

Genomic loss of heterozygosity and survival in the REAL3 trial
por: Smyth, Elizabeth C., et al.
Publicado: (2018)

Value of the loss of heterozygosity to BRCA1 variant classification
por: Santana dos Santos, Elizabeth, et al.
Publicado: (2022)

Equitable machine learning counteracts ancestral bias in precision medicine, improving outcomes for all
por: Smith, Leslie A, et al.
Publicado: (2023)

Follicular Thyroid Adenoma and Follicular Thyroid Carcinoma—A Common or Distinct Background? Loss of Heterozygosity in Comprehensive Microarray Study
por: Borowczyk, Martyna, et al.
Publicado: (2023)

Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma
por: Lamm, Wolfgang, et al.
Publicado: (2014)

Loss of heterozygosity on the long arm of chromosome 11 in colorectal tumours.
por: Gustafson, C. E., et al.
Publicado: (1994)

Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma.
por: Foulkes, W. D., et al.
Publicado: (1993)

Sequential loss of heterozygosity in the progression of squamous cell carcinoma of the lung.
por: Endo, C., et al.
Publicado: (1998)

Stress Alters Rates and Types of Loss of Heterozygosity in Candida albicans
por: Forche, A., et al.
Publicado: (2011)

Loss of heterozygosity and SOSTDC1 in adult and pediatric renal tumors
por: Blish, Kimberly R, et al.
Publicado: (2010)

Loss of Heterozygosity Drives Clonal Diversity of Phytophthora capsici in China
por: Hu, Jian, et al.
Publicado: (2013)

Association of Loss of Heterozygosity at the p53 Locus with Chemoresistance in Osteosarcomas
por: Goto, Akiteru, et al.
Publicado: (1998)

Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy
por: Rendo, Veronica, et al.
Publicado: (2020)

Targeting Loss of Heterozygosity: A Novel Paradigm for Cancer Therapy
por: Zhang, Xiaonan, et al.
Publicado: (2021)

Overdominant Mutations Restrict Adaptive Loss of Heterozygosity at Linked Loci
por: Fisher, Kaitlin J, et al.
Publicado: (2021)

Genome-scale patterns in the loss of heterozygosity incidence in Saccharomyces cerevisiae
por: Tutaj, Hanna, et al.
Publicado: (2022)

Genome plasticity driven by aneuploidy and loss of heterozygosity in Trypanosoma cruzi
por: Cruz-Saavedra, Lissa, et al.
Publicado: (2022)

PB1836: LOSS OF HETEROZYGOSITY IN AML PATIENTS WITH INV(16)
por: Bessmertniy, Dmitry, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mlok6alnc6k6t8tei6ghvq9f9v